PLOS: A Global Biomedical R&D Fund and Mechanism for Innovations of Public Health Importance
Manica Balasegaram, Christian Bréchot, Jeremy Farrar, David Heymann, Nirmal Ganguly, Martin Khor, Yves Lévy, Precious Matsoso, Ren Minghui, Bernard Pécoul , Liu Peilong, Marcel Tanner, John-Arne Røttingen
17 June 2015
- Anti-microbial resistance, emerging infectious diseases, and
neglected diseases are all important public health concerns and
priorities with serious market failures, deficits, and identified needs
in biomedical innovation.
- It is important to reconcile, rather than fragment, the needs of
these three priority areas by considering an umbrella framework for
specifically financing and coordinating research and development
(R&D) that delivers innovation while securing patient access.
- A sizeable, sustainably financed global R&D fund and mechanism
that promotes coordination, collaboration, and utilization of new and
innovative incentives should be set up to cover all three priority